get a key
steadybase-$ company BFRG
account_id none on file
legal_name BullFrog AI Holdings, Inc.
ticker BFRG
cik 1829247
domain bullfrogai.com
entry_point_account_id none on file
name Bullfrog AI Holdings Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 47 executives 1 family 0
why_nownone on file
callsnone on file
filings
These increases could include increased costs related to the hiring of additional personnel and fees to outside consultants, lawyers, and accountants, among other expenses.

filing / Aug 14, 2026 / receipt

These increases could include increased costs related to the hiring of additional personnel and fees to outside consultants, lawyers, and accountants, among other expenses.

filing / Aug 14, 2026 / receipt

These increases could include increased costs related to the hiring of additional personnel and fees to outside consultants,

filing / May 14, 2026 / receipt

These increases could include increased costs related to the hiring of additional personnel and fees to outside consultants,

filing / May 14, 2026 / receipt

2026 shift to commercialization and enterprise adoption, integrated platform and early AI technology validation

ir_statement / Sep 16, 2026 / receipt

Closing and executing commercial agreements, contracts, and partnerships with large pharmaceutical companies

ir_statement / Sep 16, 2026 / receipt

Expanding commercial agreement with Top 5 global pharmaceutical across R&D with BullFrog’s integrated drug intelligence platform

ir_statement / Sep 16, 2026 / receipt

Closing and executing commercial agreements, contracts, and partnerships with large pharmaceutical companies

ir_statement / Sep 16, 2026 / receipt

Expanding commercial agreement with Top 5 global pharmaceutical across R&D with BullFrog’s integrated drug intelligence platform

ir_statement / Sep 16, 2026 / receipt

Strategic channel partners ramp revenue

ir_statement / Sep 16, 2026 / receipt

2026 shift to commercialization and enterprise adoption, integrated platform and early AI technology validation

ir_statement / Sep 16, 2026 / receipt

Closing and executing commercial agreements, contracts, and partnerships with large pharmaceutical companies

ir_statement / Sep 16, 2026 / receipt

executives
Josh Blacher Chief Financial Officer - receipt
familynone on file
upcoming
2026-11-13 earnings call scheduled ir
changes
2024-12-17 Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$